Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease

NCT02203578 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Graft Versus Host Disease

Interventions

DRUG: romidepsin
OTHER: laboratory biomarker analysis

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]